Objective To estimate the biological exposure limit （BEL） using benchmark dose （BMD） based on two sets of data from occupational epidemiology. Methods Cadmium-exposed workers were selected from a cadmium smelting ...Objective To estimate the biological exposure limit （BEL） using benchmark dose （BMD） based on two sets of data from occupational epidemiology. Methods Cadmium-exposed workers were selected from a cadmium smelting factory and a zinc product factory. Doctors, nurses or shop assistants living in the same area served as a control group. Urinary cadmium （UCd） was used as an exposure biomarker and urinary D2-microgloburin （B2M）, N-acetyl-D-D-glucosaminidase （NAG） and albumin （ALB） as effect biomarkers. All urine parameters were adjusted by urinary creatinine. Software of BMDS （Version 1.3.2, EPA.U.S.A） was used to calculate BMD. Results The cut-off point （abnormal values） was determined based on the upper limit of 95% of effect biomarkers in control group. There was a significant dose response relationship between the effect biomarkers （urinary B2M, NAG9 and ALB） and exposure biomarker （UCd）. BEL value was 5 μg/g creatinine for UB2M as an effect biomarker, consistent with the recommendation of WHO. BEL could be estimated by using the method of BMD. BEL value was 3 μg/g creafinine for UNAG as an effect biomarker. The more sensitive the used biomarker is, the more occupational population will be protected. Conclusion BMD can be used in estimating the biological exposure limit （BEL）. UNAG is a sensitive biomarker for estimating BEL after cadmium exposure.展开更多
目的应用基准剂量法探讨燃煤氟砷污染致暴露人群骨代谢损伤的生物暴露限值,为预防氟砷暴露对人体健康的损害提供骨损害方面的参考依据。方法应用BMDS Version 2.1.2软件计算氟砷暴露人群尿氟、尿砷的基准剂量(BMD)及其可信限下限(BMDL)...目的应用基准剂量法探讨燃煤氟砷污染致暴露人群骨代谢损伤的生物暴露限值,为预防氟砷暴露对人体健康的损害提供骨损害方面的参考依据。方法应用BMDS Version 2.1.2软件计算氟砷暴露人群尿氟、尿砷的基准剂量(BMD)及其可信限下限(BMDL)。结果氟、砷混合暴露引起骨代谢损伤的尿氟BMD及BMDL分别为1.96mg/gCr、1.32 mg/gCr;尿砷BMD及BMDL分别为120.11μg/gCr、94.83μg/gCr。结论建议氟、砷混合暴露引起暴露人群骨代谢损伤尿氟和尿砷的生物暴露限值分别为1.32 mg/gCr和94.83μg/gCr。展开更多
文摘Objective To estimate the biological exposure limit （BEL） using benchmark dose （BMD） based on two sets of data from occupational epidemiology. Methods Cadmium-exposed workers were selected from a cadmium smelting factory and a zinc product factory. Doctors, nurses or shop assistants living in the same area served as a control group. Urinary cadmium （UCd） was used as an exposure biomarker and urinary D2-microgloburin （B2M）, N-acetyl-D-D-glucosaminidase （NAG） and albumin （ALB） as effect biomarkers. All urine parameters were adjusted by urinary creatinine. Software of BMDS （Version 1.3.2, EPA.U.S.A） was used to calculate BMD. Results The cut-off point （abnormal values） was determined based on the upper limit of 95% of effect biomarkers in control group. There was a significant dose response relationship between the effect biomarkers （urinary B2M, NAG9 and ALB） and exposure biomarker （UCd）. BEL value was 5 μg/g creatinine for UB2M as an effect biomarker, consistent with the recommendation of WHO. BEL could be estimated by using the method of BMD. BEL value was 3 μg/g creafinine for UNAG as an effect biomarker. The more sensitive the used biomarker is, the more occupational population will be protected. Conclusion BMD can be used in estimating the biological exposure limit （BEL）. UNAG is a sensitive biomarker for estimating BEL after cadmium exposure.
文摘目的应用基准剂量法探讨燃煤氟砷污染致暴露人群骨代谢损伤的生物暴露限值,为预防氟砷暴露对人体健康的损害提供骨损害方面的参考依据。方法应用BMDS Version 2.1.2软件计算氟砷暴露人群尿氟、尿砷的基准剂量(BMD)及其可信限下限(BMDL)。结果氟、砷混合暴露引起骨代谢损伤的尿氟BMD及BMDL分别为1.96mg/gCr、1.32 mg/gCr;尿砷BMD及BMDL分别为120.11μg/gCr、94.83μg/gCr。结论建议氟、砷混合暴露引起暴露人群骨代谢损伤尿氟和尿砷的生物暴露限值分别为1.32 mg/gCr和94.83μg/gCr。
